Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy

ClinicalTrials.gov ID: NCT02489617

Public ClinicalTrials.gov record NCT02489617. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 27, 2026, 6:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research study is studying a surgical intervention to rule out the presence of cancer in participants that have been diagnosed with flat epithelial atypia (FEA) or intraductal papilloma without atypia (IPWA) by core needle biopsy.

Study identification

NCT ID
NCT02489617
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Enrollment
246 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2015
Primary completion
Nov 30, 2021
Completion
May 31, 2025
Last update posted
Oct 5, 2025

2015 – 2025

United States locations

U.S. sites
18
U.S. states
9
U.S. cities
14
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
Georgetown University Washington D.C. District of Columbia 20007 —
MedStar Washington Hospital Center Washington D.C. District of Columbia 20010 —
Sibley Memorial Hospital Washington D.C. District of Columbia 20016 —
Indiana University Indianapolis Indiana 46202 —
MedStar Union Memorial Hospital Baltimore Maryland 21218 —
MedStar Franklin Square Medical Center Baltimore Maryland 21237 —
Johns Hopkins University Baltimore Maryland 21287 —
Howard County General Hospital Columbia Maryland 21044 —
Dana Farber Cancer Institute Boston Massachusetts 02115 —
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 —
Memorial SLoan Kettering Bergen Montvale New Jersey 07645 —
Memorial Sloan Kettering Cancer Center New York New York 10065 —
Montefiore Medical Center The Bronx New York 10461 —
University of North Carolina Chapel Hill North Carolina 27599 —
Duke University Durham North Carolina 27710 —
University of North Carolina - Hillsborough Campus Hillsborough North Carolina 27278 —
University of Pittsburgh Pittsburgh Pennsylvania 15213 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02489617, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 5, 2025 · Synced Sep 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02489617 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →